ATARA Biotherapeutics (ATRA) Tops Q2 EPS by 19c

ATARA Biotherapeutics (NASDAQ: ATRA) reported Q2 EPS of $0.19. Revenue for the quarter came in at $17.58 million.

For earnings history and earnings-related data on ATARA Biotherapeutics (ATRA) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Morgan Stanley Resumes OMV AG (OMV:AV) (OMVKY) at Equalweight
• Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank